Previous Article | Next Article ![]()
Infect Immun, February 1998, p. 835-838, Vol. 66, No. 2
Microbiology Department, Chicago College of
Osteopathic Medicine, Midwestern University, Downers Grove,
Illinois 60515,1 and
Department of
Medical Microbiology and Immunology, University of Wisconsin
Medical School, Madison, Wisconsin 537062
Received 10 September 1997/Returned for modification 22 October
1997/Accepted 11 November 1997
Mice lacking inducible nitric oxide synthase (iNOS) or treated with
iNOS inhibitors resolved chlamydial genital tract infections. Additionally, treatment of primary murine cell cultures with gamma interferon restricted chlamydial growth in the absence of nitric oxide. From these results, iNOS activity is unnecessary for the resolution of chlamydial genital tract infections in mice and inhibition of chlamydial growth in culture.
Several studies indicate that
resolution of primary chlamydial genital tract infections and
protection from a secondary infection in female mice require T-helper
type 1 (Th1) lymphocytes. Athymic mice or mice lacking major
histocompatibility complex class II antigens fail to resolve genital
tract infections with the mouse pneumonitis biovar (MoPn) of
Chlamydia trachomatis (20, 24), but mice depleted
of B cells (22) or deficient in the production of antibody
(26) resolve the infection. Also, chronic infection is
resolved in MoPn-specific Th1 lymphocytes following adoptive transfer
into athymic mice (15, 21), and infection is prolonged in CD4-deficient mice (20). Lastly, gamma interferon
(IFN- One important mechanism of IFN- Thus, the purpose of this study was to further examine the role of iNOS
in chlamydial genital tract infections in mice and in primary murine
cell culture. Mice with a targeted disruption in the iNOS gene (iNOS
KO) or mice treated with specific chemical inhibitors of iNOS were used
for this purpose. Breeding pairs of iNOS KO mice were obtained from
Edward Balish (University of Wisconsin-Madison Gnotobiotic Laboratory)
under a material transfer agreement with John Mudgett (Merck & Co.,
Rahway, N.J.) to initiate a colony at Midwestern University. The
specific disruption in the iNOS gene and promoter are described
elsewhere (18). The iNOS KO was confirmed at the molecular
level by PCR with genomic DNA by using primer pairs specific for the
targeting vector containing the neomycin resistance gene as previously
described (9). We also verified the iNOS KO by assessing
nitrite accumulation in primary cell cultures derived from various
tissues of iNOS KO mice in response to IFN- Eight- to 12-week-old mice were infected intravaginally with 100 50%
infective doses of C. trachomatis MoPn (Weiss strain) in 5 µl of SPG buffer (10 mM phosphate, 0.25 M sucrose, 5 mM
L-glutamic acid [pH 7.2]) containing between 5 × 103 and 1 × 104 inclusion-forming units
(IFU) (5, 9) after treatment with 2.5 mg of progesterone, as
previously described (8). The infection was assessed by the
sequential collection of cervical-vaginal swabs (Calgiswab, type 1;
Spectrum Diagnostics, Houston, Tex.) at 4, 7, 10, and 14 days
postinfection and every 7 days thereafter until cessation of chlamydial
shedding. MoPn was isolated in HeLa cell cultures and enumerated by
indirect fluorescence microscopy as previously described
(9).
In order to monitor iNOS activity, urine nitrite and nitrate levels,
which correlate with nitric oxide production in vivo, were determined.
Urine was collected daily from mice housed in metabolism cages and fed
a nitrate- and nitrite-free diet. Urine nitrate and nitrite content was
determined by the Greiss reaction (11). On the day of
infection, the drinking water of the experimental group was spiked with
50 mM L-NMMA (CYCLOPPS Corp., Salt Lake City, Utah), an iNOS
inhibitor. Drinking water was replaced daily. iNOS KO mice were not
assessed for urine nitrate output and received their normal diet of
autoclaved chow and sterile water.
The results presented in Fig. 1 show the
course of chlamydial infection in wild-type animals receiving either
Millipore drinking water spiked with 50 mM L-arginine (Fig. 1A) or
L-NMMA-spiked drinking water (Fig. 1B) and in iNOS KO mice (Fig.
1C). Mice receiving L-NMMA did not have significantly prolonged
infection compared with those receiving no treatment despite marked
inhibition of iNOS activity as indicated by urinary nitrite excretion.
Additionally, in 14 of 15 iNOS KO mice the infection was resolved over
the 42-day monitoring period, with the one remaining infected mouse at
day 42 shedding less than 100 IFU of viable MoPn. Statistical analysis of the percentage of animals remaining infected at each of the times
indicated no significant differences in the duration of infection
between any of the three groups (two-factor analysis of the variance
with repeated measures of one factor). Nonetheless, in the remaining
culture-positive iNOS KO mice at day 14 postinfection and in the
L-NMMA-treated wild-type animals at day 10, significantly higher
numbers of IFU were isolated compared to those in the wild-type controls (P < 0.02 by a two-tailed t
test). Similar results were observed in another experiment
comparing animals given aminoguanidine with those receiving
Millipore water only (data not shown). These results indicate that
while iNOS may be involved in controlling chlamydial replication during
the midpoint of the infection, its activity is not essential to
resolution of the infection.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Inducible Nitric Oxide Synthase Does Not Affect Resolution of
Murine Chlamydial Genital Tract Infections or Eradication of
Chlamydiae in Primary Murine Cell Culture
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
) contributes to the control of murine chlamydial genital tract infections (9, 17, 23) and to inhibition of chlamydial growth in culture (3, 25).
-dependent inhibition of chlamydial
growth in the mouse may be the activity of inducible nitric oxide
synthase (iNOS) (10). For example, specific inhibition of
iNOS was reported to reverse IFN-
-mediated inhibition of chlamydial growth in murine fibroblasts (19) and macrophages
(7). Igietseme and colleagues (13, 16) found that
protective IFN-
-secreting T-cell clones restrict chlamydial growth
by inducing nitric oxide production in MoPn-infected murine epithelial
cells. This inhibition was reversed in the presence of the
L-arginine analog
NG-monomethyl-L-arginine (L-NMMA),
an inhibitor of iNOS activity. However, Chen et al. (7)
reported that neither iNOS nor the induction of indoleamine
2,3-dioxygenase (IDO), a tryptophan-decyclizing enzyme responsible for
inhibition of chlamydial growth in IFN-
-treated human cells in
culture (4, 27), could fully account for the IFN-
-mediated effects. Therefore, Th1-mediated protective immunity in the immunocompetent mouse may involve IFN-
-mediated mechanisms other than iNOS activity.
and lipopolysaccharide
(LPS) in comparison to that in wild-type controls (11). For
wild-type controls, 6- to 8-week-old C57BL/6hsd mice were obtained from
Harlan Sprague Dawley, Inc., Indianapolis, Ind. In some experiments,
control animals were derived by breeding 129/SvEv female mice with
C57BL/6J males to obtain the F1 parental hybrid strain from
which the knockout was derived (18).

View larger version (23K):
[in a new window]
FIG. 1.
Role of iNOS in chlamydial genital tract infection in
vivo. The course of infection (solid line) and urine nitrate levels
(dashed line) in wild-type C57BL/6 mice receiving either 50 mM
L-arginine (A) or 50 mM L-NMMA (B) in their drinking water and in iNOS
KO mice (C) is shown. Each data point represents the mean IFU from
cervical-vaginal swabs of culture-positive mice collected 4, 7, 10, 14, 21, 28, 35, and 42 days postinfection. Above each data point, the ratio
of the number of culture-positive animals to the total number of
animals in each experimental group is given. The asterisks in panels B
and C designate significant differences in the quantitative recovery of
viable MoPn at the indicated times postinfection compared to that in
the control mice (panel A). Urine was collected daily for nitrate
determination. The urinary nitrate response was not assessed in iNOS KO
mice.
We then sought to determine the reason for the apparent disparity in
the observations in our experiments and in those of previously published works (7, 14, 19). We hypothesized that
IFN-
controlled chlamydial replication independently of iNOS
activity. Therefore, we assessed the effect of IFN-
on
chlamydial replication in various cells derived from iNOS KO and
control mice.
Following sacrifice of uninfected iNOS KO or control animals, organs were aseptically removed and processed to obtain single-cell suspensions by a standard collagenase D stainless-steel mesh filtration procedure. Cells were plated in Eagle's minimal essential medium containing 10% heat-inactivated (56°C, 30 min) fetal bovine serum and 2 mM L-glutamine at 1 ml per well in 24-well plates. Primary cell cultures were monitored daily with an inverted microscope and fed by replacing medium at 2- or 3-day intervals. Upon reaching confluency or near confluency (usually 9 to 12 days in culture), the cells were used in the nitric oxide induction and chlamydial growth assays described below. To obtain peritoneal macrophages, cells were harvested by peritoneal lavage 72 h after intraperitoneal injection with 1 ml of 3% Proteose Peptone (DIFCO, Detroit, Mich.). Following enumeration, the cell suspension was diluted to 2 × 105 cells/ml, plated at 1 ml per well in 24-well plates in Eagle's minimal essential medium with 10% fetal bovine serum, and allowed to adhere for 24 h prior to use.
Initially, single-cell preparations from several tissues were screened for their ability to form monolayers in culture and to support chlamydial growth. From these results, we determined that cell cultures from urinary bladder and lung tissues were best suited for our purposes. These preparations from iNOS KO and control mice were found to be predominantly fibroblasts at confluency by indirect fluorescent-antibody staining with fibroblast-specific goat antivimentin (1:20; ICN Biomedical, Aurora, Ohio) followed by fluorescein-labeled rabbit anti-goat immunoglobulin (1:200; ICN Biomedical).
Treatment of murine cells with IFN-
and LPS induces iNOS to produce
nitric oxide from L-arginine, resulting in the accumulation of nitrite in culture supernatants. This response can be blocked by the presence of the arginine analog L-NMMA (12).
Therefore, we assessed nitrite accumulation in the primary cell
cultures described above in response to IFN-
and LPS in the presence
and absence of L-NMMA. Culture medium was aspirated from primary
murine cell lines and macrophages and replaced with medium containing either IFN-
(50 ng/ml; Pharmingen, San Diego, Calif.) plus LPS (100 ng/ml; Sigma), IFN-
plus LPS plus 1 mM L-NMMA (Calbiochem, La
Jolla, Calif.), fresh medium plus L-NMMA, or fresh medium only for
48 h. Nitrite accumulation was assessed by the Greiss reaction (11). Treatment of cells from control mice with IFN-
and
LPS resulted in marked nitrite production in the supernatants of each of the primary cultures (P < 0.005, by a two-tailed
t test, in each case compared with that in controls with
medium only) while the presence of L-NMMA completely reversed this
response (data not shown). As expected, no nitrite was detected at any
time in supernatants of primary cell cultures derived from iNOS KO
mice. We also assessed IDO activity by previously published methods (6) but were unable to detect any activity, as indicated by a lack of accumulated tryptophan catabolites in the culture
supernatants (data not shown).
Parallel cultures were also infected with 4 × 105 IFU
of HeLa-grown MoPn per well, incubated for 40 h at 37°C in a
humidified atmosphere of 5% CO2, washed once with
phosphate-buffered saline, and fixed with methanol. Chlamydial
inclusions were stained by an indirect fluorescent-antibody method and
enumerated as described elsewhere (9). The results presented
in Fig. 2 show that treatment with
IFN-
plus LPS restricts chlamydial growth in primary cultures of
each of the tissues derived from both iNOS KO and control animals (P < 0.0001 in each case by comparing the numbers of
IFU in IFN-
-plus-LPS-treated cultures to those in untreated cultures
by a two-tailed t test). This inhibition of chlamydial
growth was not significantly reversed in the presence of L-NMMA,
indicating that mechanisms other than iNOS activity are responsible for
IFN-
restriction of chlamydial growth in cultured murine cells.
|
Our findings appear to contradict those of others who have examined the
role of nitric oxide in chlamydial infections. For example, Mayer et
al. described IFN-
-mediated inhibition of chlamydial growth in
murine fibroblasts that was attributable to nitric oxide production
(19). In several studies, Igietseme et al. have described the use of a MoPn-specific Th1 clone to determine the role of nitric
oxide-mediated restriction of chlamydial growth in vitro (13,
16) and in vivo (14). The activity of the clone
against chlamydiae was inhibited by the presence of L-NMMA. The
differences between our current findings and the previous findings
described above are likely due to the fact that in the in vivo system
used in our study other factors are present and may play a role in the
absence of iNOS. These factors may be absent in the athymic mouse model
and in the clonal in vitro coculture systems employed by Igietseme et
al. Hence, compensatory mechanisms effectively control chlamydial
replication in the absence of iNOS activity. Indeed, a multitude of
both IFN-
-dependent and -independent mechanisms likely work together
in the immunocompetent mouse to effect clearance of the infection.
In similar studies, Chen et al. (7) found that although
inhibition of iNOS activity resulted in a partial reversal of
chlamydial growth inhibition, the activity of neither iNOS nor IDO
could fully account for the observed effects of treatment with IFN-
plus LPS in the RAW264.7 murine macrophage cell line or in freshly isolated murine peritoneal macrophages. These findings lend credence to
the conclusion that a third, unidentified IFN-
-mediated mechanism may be in effect.
Interestingly, we did observe a tendency of iNOS KO and wild-type mice treated with chemical inhibitors of iNOS to shed higher numbers of organisms between 10 and 14 days postinfection than did controls. Others have reported similar differences in quantitative recovery of the organism early in the course of infection in mice treated with L-NMMA (14).
Although previous studies indicate that IFN-
is present in
endocervical secretions in humans during chlamydial infection, the
precise role of IFN-
in humans in vivo is not known (2). In vitro, in human cells IFN-
induces IDO, which is responsible for
inhibition of chlamydial growth via tryptophan starvation (4, 6,
27). Others have reported IDO activity in murine macrophages in
response to IFN-
, and this activity appears to be negatively
regulated by the activity of iNOS (1). However, we did not
detect IDO activity in primary murine cell culture in response to
IFN-
and LPS in iNOS KO or control mice. This finding suggests that
tryptophan catabolism is not likely to be the compensatory mechanism
used by iNOS KO mice to control the infection. A third,
yet-unidentified, IFN-
-mediated mechanism may be in effect and is
currently under investigation.
| |
ACKNOWLEDGMENTS |
|---|
We thank Edward Balish, John Mudgett, and Merck & Co. for providing the iNOS KO mice.
This work was supported by Public Health Service grants AI37807 (to K.H.R.) and AI19782 (to G.I.B.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Microbiology Department, Chicago College of Osteopathic Medicine, Midwestern University, 555 31st St., Downers Grove, IL 60515. Phone: (630) 515-6165. Fax: (630) 515-7245. E-mail: kramse{at}midwestern.edu.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Alberati-Giani, D.,
P. Malherbe,
P. Ricciardi-Castagnoli,
C. Kohler,
S. Dennis-Donini, and A. M. Cesura.
1997.
Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN- -activated murine macrophages and microglial cells.
J. Immunol.
159:419-426[Abstract].
|
| 2. | Arno, J. N., V. A. Ricker, B. E. Batteiger, B. P. Katz, V. A. Caine, and R. B. Jones. 1990. Interferon-gamma in endocervical secretions of women infected with Chlamydia trachomatis. J. Infect. Dis. 162:1385-1389[Medline]. |
| 3. |
Byrne, G. I., and D. A. Krueger.
1983.
Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.
Infect. Immun.
42:1152-1158 |
| 4. |
Byrne, G. I.,
L. K. Lehmann, and G. J. Landry.
1986.
Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells.
Infect. Immun.
53:347-351 |
| 5. |
Caldwell, H. D.,
J. Kromhout, and J. Schachter.
1981.
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.
Infect. Immun.
31:1161-1176 |
| 6. | Carlin, J. M., E. C. Borden, and G. I. Byrne. 1989. Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J. Interferon Res. 9:329[Medline]. |
| 7. |
Chen, B.,
R. Stout, and W. F. Campbell.
1996.
Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon- treated RAW264.7 cells.
FEMS Immunol. Med. Microbiol.
14:109-120[Medline].
|
| 8. | Cotter, T. W., Q. Meng, Z.-L. Shen, Y.-X. Zhang, H. Su, and H. D. Caldwell. 1996. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4704-4714[Abstract]. |
| 9. | Cotter, T. W., K. H. Ramsey, G. S. Miranpuri, C. E. Poulsen, and G. I. Byrne. 1997. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect. Immun. 65:2145-2152[Abstract]. |
| 10. | Ding, A. H., C. F. Nathan, and D. J. Stueher. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. J. Immunol. 141:2407-2412[Abstract]. |
| 11. | Granger, D. L., J. B. Hibbs, and L. M. Broadnax. 1991. Urinary nitrate excretion in relation to murine macrophage activation: influence of dietary L-arginine and oral NG-monomethyl-L-arginine. J. Immunol. 146:1294-1302[Abstract]. |
| 12. |
Hibbs, J. B.,
R. R. Taintor, and V. Zdenek.
1987.
Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.
Science
235:473-476 |
| 13. | Igietseme, J. U. 1996. The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide. Immunology 87:1-8[Medline]. |
| 14. | Igietseme, J. U. 1996. Molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide in vivo. Immunology 88:1-5[Medline]. |
| 15. | Igietseme, J. U., K. H. Ramsey, D. M. Magee, T. J. Kincy, and R. G. Rank. 1994. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific Th1 T cell clone. Reg. Immunol. 5:317-324. |
| 16. | Igietseme, J. U., I. M. Uriri, R. Hawkins, and R. G. Rank. 1997. Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia. J. Leukocyte Biol. 59:656-662[Abstract]. |
| 17. | Johansson, M., K. Schon, M. Ward, and N. Lycke. 1997. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65:1032-1044[Abstract]. |
| 18. | MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650[Medline]. |
| 19. |
Mayer, J.,
M. L. Woods,
Z. Vavrin, and J. B. Hibbs.
1993.
Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells.
Infect. Immun.
61:491-498 |
| 20. | Morrison, R. P., K. Feilzer, and D. B. Tumas. 1995. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4661-4668[Abstract]. |
| 21. |
Ramsey, K. H., and R. G. Rank.
1991.
Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines.
Infect. Immun.
59:925-931 |
| 22. |
Ramsey, K. H.,
L. S. F. Soderberg, and R. G. Rank.
1988.
Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection.
Infect. Immun.
56:1320-1325 |
| 23. |
Rank, R. G.,
K. H. Ramsey,
E. A. Pack, and D. M. Williams.
1992.
Effect of gamma interferon on resolution of murine chlamydial genital infection.
Infect. Immun.
60:4427-4429 |
| 24. |
Rank, R. G.,
L. S. F. Soderberg, and A. L. Barron.
1985.
Chronic chlamydial genital infection in congenitally athymic nude mice.
Infect. Immun.
48:847-849 |
| 25. |
Rothermel, C. D.,
B. Y. Rubin, and H. W. Murray.
1983.
IFN is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.
J. Immunol.
131:2542-2544[Abstract].
|
| 26. | Su, H., H. D. Caldwell, and R. P. Morrison. 1997. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect. Immun. 65:1993-1999[Abstract]. |
| 27. |
Thomas, S. M.,
L. F. Garrity,
C. R. Brandt,
S. C. Schobert,
G. S. Feng,
M. W. Taylor,
J. M. Carlin, and G. I. Byrne.
1993.
The IFN-mediated antimicrobial response: indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth.
J. Immunol.
150:5529-5534[Abstract].
|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|